?

Patient selection**: Which patients are most likely to respond?

active
open question Created: 2026-04-25T20:29:10 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-d2807210-3ef4-4f47-b504-68
Open Question open Wiki: therapeutics-etalanetug-e2814
Patient selection**: Which patients are most likely to respond?
Importance Elo
1500
Field Rank
Rank #998 in therapeutics
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page therapeutics-etalanetug-e2814
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
therapeutics
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:10.604442'}
field_tagtherapeutics
source_idtherapeutics-etalanetug-e2814
sub_fieldetalanetug-e2814
source_kindwiki
question_hash3e10aea94b1a274eeeee8bc47bbfa6642b8d47c93c9beacec1392c6df2153845
question_textPatient selection**: Which patients are most likely to respond?
importance_elo1500
_schema_version1
evidence_summaryExtracted from wiki page therapeutics-etalanetug-e2814
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.